World EPA Congress 2024


The World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in market access, pricing, and evidence, hosting over 300 speakers, 8 tracks, and drawing over 1500 attendees from pharmaceuticals, biotech, and Payers/HTA’s.

In its 2024 edition, the congress extends to a two-day event, introducing the Health Economics & Outcomes Research track and a dedicated poster area to bolster academic participation and deepen discussions. Core topics such as Market Access and Pricing, Rare Diseases, HTA/Payer, and Evidence will be enriched with insights into reimbursement trends, payment models, affordability, and HEOR advancements.

The congress proudly collaborates with prominent solution providers including Remap Consulting, a Platinum sponsor, offering an integrated approach to pricing and market access, and sharing thought leadership with key stakeholders in the pharmaceutical and biotech industries.

On this webpage you will find our daily summaries of the keynotes, core sessions, post-conference report and the research that we presented at the conference.

Our team

Our conference team this year boast expertise spanning a wide range of areas, including health economics, RWE, market access, and HTA.

If you’d like to arrange a meeting with any of our attendees post-conference then please contact us here.

Our programme of events

We’re delighted to have the opportunity to host a HTA track talk and chair another, and present the below research at World EPA Congress this year, and we look forward to many engaging conversations with you.

DateEventTimeTeam Member
12th MarchA presentation by Remap Consulting:
Opportunities for manufacturers arising from EU HTA
12.05pmGraham Foxon
13th MarchResearch by Remap Consulting:
Implications of indication expansions on pricing and reimbursement and how this differs between EU4 and UK markets
10.40am – 11.30amGillian Nicol, Rahul Vadehra, Manahill Baig
13th MarchHTA Track: Chair’s Remarks and Session3.10pmJanice Haigh

Be sure to speak to Gill, Mani and Rahul for more information and insights.


Just like in past years, Remap Consulting have crafted daily summaries of the essential conference topics, including the plenary sessions. Plus, for extra insights, subscribe to our newsletter below.

Day 1 summary
Day 2 summary

Access the full report below.

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.